Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance

Indian J Med Sci. 2006 Feb;60(2):53-8.

Abstract

Background: A high prevalence of antimicrobial resistance among urinary isolates in the Garhwal region of Uttaranchal.

Aims: To identify the most appropriate antibiotic for empirical treatment of community-acquired acute cystitis on the basis of local antimicrobial sensitivity profile.

Settings and design: A prospective clinico-microbiological study including all clinically diagnosed patients with community acquired acute cystitis attending a tertiary care teaching hospital over a period of three years.

Methods and material: Clean-catch midstream urine specimens, from 524 non-pregnant women with community-acquired acute cystitis, were subjected to semi-quantitative culture and antibiotic susceptibility by the Kirby- Bauer disc diffusion method. A survey was also conducted on 30 randomly selected local practitioners, to know the prevalent prescribing habits in this condition.

Statistical analysis: The difference between the susceptibility rates of E. coli isolates to Nitrofurantoin and the other commonly prescribed antibiotics was analysed by applying the z test for proportion.

Results: 354 (67.5%) specimens yielded significant growth of E. coli.> 35% of the urinary E.coli isolates were resistant to the fluoroquinolones, which were found to be the most commonly used empirical antibiotics in acute cystitis. Resistance was minimum against Nitrofurantoin (9.3%, 33) and Amikacin (11.0%,39).> 80% of the fluoroquinolone-resistant strains were found to be sensitive to Nitrofurantoin.

Conclusion: The best in vitro susceptibility profile in our study has been shown by Nitrofurantoin and a significantly high proportion of the urinary E. coli isolates have already developed resistance to the currently prescribed empirical antibiotics, viz. the fluoroquinolones. In view of these in vitro susceptibility patterns, a transition in empirical therapy appears imminent.

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Infective Agents, Urinary / therapeutic use*
  • Bacterial Infections / drug therapy
  • Cystitis / drug therapy
  • Cystitis / microbiology*
  • Drug Resistance, Microbial*
  • Escherichia coli / drug effects
  • Female
  • Humans
  • India
  • Klebsiella / drug effects
  • Microbial Sensitivity Tests*
  • Middle Aged
  • Nitrofurantoin / therapeutic use*
  • Prospective Studies
  • Proteus / drug effects
  • Staphylococcus / drug effects
  • Urine / microbiology

Substances

  • Anti-Infective Agents, Urinary
  • Nitrofurantoin